Novartis India Ltd
NOVARTIND
Company Profile
Business description
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment, namely Pharmaceutical Business. Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
Contact
Inspire BKC
Part of 601 & 701, Bandra Kurla Complex
Bandra (East)
MumbaiMH400 051
INDT: +91 2250243000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
61
Stocks News & Analysis
stocks
Lower production and higher prices for ASX hydrocarbon play
Improving pricing offsets severe weather impact on sales volumes.
stocks
Alphabet returns on AI investments accelerating
AI propels business across aegments, cloud is grightest; Increasing our fair value.
stocks
We lift our fair value estimate for this ASX energy play
Strong oil and LNG prices are a major win, though we don’t think they will stay high in the long term.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,887.60 | 17.10 | 0.19% |
| CAC 40 | 8,062.89 | 9.24 | -0.11% |
| DAX 40 | 24,095.18 | 140.62 | 0.59% |
| Dow JONES (US) | 49,243.21 | 381.40 | 0.78% |
| FTSE 100 | 10,360.93 | 147.82 | 1.45% |
| HKSE | 25,776.53 | 335.31 | -1.28% |
| NASDAQ | 24,579.97 | 93.27 | -0.38% |
| Nikkei 225 | 59,284.92 | 632.54 | -1.06% |
| NZX 50 Index | 12,903.31 | 133.01 | 1.04% |
| S&P 500 | 7,135.51 | 0.44 | -0.01% |
| S&P/ASX 200 | 8,665.80 | 25.60 | 0.30% |
| SSE Composite Index | 4,112.16 | 4.65 | 0.11% |